Renaissance Technologies’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-116,562
Closed -$2.7M 4390
2023
Q1
$2.7M Sell
116,562
-65,100
-36% -$1.51M ﹤0.01% 1839
2022
Q4
$4.76M Sell
181,662
-37,680
-17% -$987K 0.01% 1554
2022
Q3
$4.31M Sell
219,342
-53,620
-20% -$1.05M 0.01% 1526
2022
Q2
$4.77M Buy
272,962
+6,220
+2% +$109K 0.01% 1598
2022
Q1
$4.36M Sell
266,742
-101,900
-28% -$1.67M 0.01% 1698
2021
Q4
$6.01M Sell
368,642
-162,920
-31% -$2.66M 0.01% 1402
2021
Q3
$6.78M Sell
531,562
-113,580
-18% -$1.45M 0.01% 1274
2021
Q2
$9.11M Sell
645,142
-96,700
-13% -$1.37M 0.01% 1240
2021
Q1
$11.5M Sell
741,842
-94,244
-11% -$1.46M 0.01% 1098
2020
Q4
$13.3M Sell
836,086
-40,716
-5% -$646K 0.01% 981
2020
Q3
$10.7M Sell
876,802
-52,060
-6% -$633K 0.01% 1084
2020
Q2
$10.7M Buy
928,862
+18,900
+2% +$218K 0.01% 1174
2020
Q1
$12.5M Sell
909,962
-17,700
-2% -$242K 0.01% 1024
2019
Q4
$5.47M Buy
927,662
+380,022
+69% +$2.24M ﹤0.01% 1794
2019
Q3
$2.9M Buy
547,640
+185,200
+51% +$981K ﹤0.01% 2074
2019
Q2
$2.79M Buy
362,440
+130,720
+56% +$1.01M ﹤0.01% 2158
2019
Q1
$4.61M Buy
231,720
+158,720
+217% +$3.16M ﹤0.01% 1857
2018
Q4
$964K Buy
+73,000
New +$964K ﹤0.01% 2590
2018
Q3
Sell
-11,800
Closed -$413K 3624
2018
Q2
$413K Sell
11,800
-35,660
-75% -$1.25M ﹤0.01% 2888
2018
Q1
$2.21M Sell
47,460
-15,300
-24% -$711K ﹤0.01% 2276
2017
Q4
$2.35M Sell
62,760
-23,420
-27% -$878K ﹤0.01% 2253
2017
Q3
$4.59M Buy
86,180
+35,440
+70% +$1.89M 0.01% 1829
2017
Q2
$2.89M Buy
50,740
+14,360
+39% +$818K ﹤0.01% 2052
2017
Q1
$1.96M Buy
36,380
+32,160
+762% +$1.73M ﹤0.01% 2252
2016
Q4
$241K Buy
+4,220
New +$241K ﹤0.01% 2950
2016
Q1
Sell
-6,920
Closed -$974K 3581
2015
Q4
$974K Buy
+6,920
New +$974K ﹤0.01% 2472